These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9163011)

  • 1. [Toxicity and efficacy of chemotherapy dependent on circadian time of cytostatic drug administration].
    Zuchowska-Vogelgesang B; Pernal J; Zemełka T
    Przegl Lek; 1996; 53(12):870-3. PubMed ID: 9163011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of survival of testicular cancer patients through chemotherapy].
    Miyanaga N; Hayashi H; Akaza H; Koiso K
    Gan To Kagaku Ryoho; 1995 May; 22(6):739-45. PubMed ID: 7538744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combination chemotherapy including Platidiam in the treatment of malignant testicular tumors.
    Garin AM; Lichinitser MR; Khlebnov AV; Tyulyandin SA
    Neoplasma; 1987; 34(1):85-8. PubMed ID: 2436066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
    Matsuzaki J; Miyoshi Y; Miura T
    Hinyokika Kiyo; 2000 Dec; 46(12):879-86. PubMed ID: 11211804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of cisplatin alone and in combination within the scope of primary therapy of ovarian cancer. Results of a prospective multicenter study].
    Richter P; Krafft W; Müller U; Brückmann D; Homann S; König EM; Lotze P; Morack G; Neubert S; Nöschel H
    Zentralbl Gynakol; 1990; 112(7):421-9. PubMed ID: 1695049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.
    Bodrogi I; Baki M; Hindy I; Eckhardt S
    Neoplasma; 1983; 30(5):557-61. PubMed ID: 6197662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness of platinum in mono- anc combination therapy in a prospective multicenter study].
    Krafft W
    Zentralbl Gynakol; 1989; 111(14):938-46. PubMed ID: 2678834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular cancer: an oncological success story.
    Einhorn EH
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2630-2. PubMed ID: 10068265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
    Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
    Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
    Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of advanced testicular cancer.
    Williams SD; Loehrer PJ; Einhorn LH
    Semin Urol; 1984 Nov; 2(4):230-7. PubMed ID: 6209762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
    Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
    Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary evaluation of the effectiveness of a modified treatment program in patients with malignant testicular neoplasms].
    Madej G; Siedlecki P; Meyza J
    Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):836-40. PubMed ID: 2446291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.